Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Kaeda

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Leukemia|September 23, 2006
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemiaS Branford, N C P Cross, A Hochhaus, et al.
British Journal of Haematology|November 1, 1992
A distinct large granular lymphocyte (LGL)/NK-associated (NKa) abnormality characterized by membrane CD4 and CD8 coexpression. The Yorkshire Leukaemia GroupS J Richards, M Sivakumaran, L A Parapia, et al.
Leukemia Research|March 24, 2004
Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinibS Avery, E Nadal, D Marin, et al.
Cancer Research|July 26, 2000
Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)S Kulkarni, C Heath, S Parker, et al.
Bone Marrow Transplantation|October 19, 2001
Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusionsK Cwynarski, R Goulding, C Pocock, et al.
British Journal of Haematology|July 27, 2001
Analysis of chimaerism in thalassaemic children undergoing stem cell transplantationP J Amrolia, T Vulliamy, G Vassiliou, et al.
Blood|October 7, 2000
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaF Dazzi, R M Szydlo, N C Cross, et al.
Leukemia|March 6, 2009
A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic responseM W Drummond, N Heaney, J Kaeda, et al.
Blood|March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, E Kanfer, R Szydlo, et al.
Leukemia|February 10, 2006
The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinibJ S Khorashad, M Anand, D Marin, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Leukemia|September 23, 2006
Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemiaS Branford, N C P Cross, A Hochhaus, et al.
British Journal of Haematology|November 1, 1992
A distinct large granular lymphocyte (LGL)/NK-associated (NKa) abnormality characterized by membrane CD4 and CD8 coexpression. The Yorkshire Leukaemia GroupS J Richards, M Sivakumaran, L A Parapia, et al.
Leukemia Research|March 24, 2004
Lymphoid transformation in a CML patient in complete cytogenetic remission following treatment with imatinibS Avery, E Nadal, D Marin, et al.
Cancer Research|July 26, 2000
Fusion of H4/D10S170 to the platelet-derived growth factor receptor beta in BCR-ABL-negative myeloproliferative disorders with a t(5;10)(q33;q21)S Kulkarni, C Heath, S Parker, et al.
Bone Marrow Transplantation|October 19, 2001
Immune haemolytic anaemia following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukaemia: association with leukaemic relapse and treatment with donor lymphocyte infusionsK Cwynarski, R Goulding, C Pocock, et al.
British Journal of Haematology|July 27, 2001
Analysis of chimaerism in thalassaemic children undergoing stem cell transplantationP J Amrolia, T Vulliamy, G Vassiliou, et al.
Blood|October 7, 2000
Durability of responses following donor lymphocyte infusions for patients who relapse after allogeneic stem cell transplantation for chronic myeloid leukemiaF Dazzi, R M Szydlo, N C Cross, et al.
Leukemia|March 6, 2009
A pilot study of continuous imatinib vs pulsed imatinib with or without G-CSF in CML patients who have achieved a complete cytogenetic responseM W Drummond, N Heaney, J Kaeda, et al.
Blood|March 10, 2001
Early detection of BCR-ABL transcripts by quantitative reverse transcriptase-polymerase chain reaction predicts outcome after allogeneic stem cell transplantation for chronic myeloid leukemiaE Olavarria, E Kanfer, R Szydlo, et al.
Leukemia|February 10, 2006
The presence of a BCR-ABL mutant allele in CML does not always explain clinical resistance to imatinibJ S Khorashad, M Anand, D Marin, et al.
Pageof 3